FDA Determines Klonopin Tablets Were Not Withdrawn for Safety Reasons
February 22, 2026
February 22, 2026
WASHINGTON, Feb. 22 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has announced that Klonopin tablets or clonazepam, 0.125 mg and 0.25 mg, were not removed from the market due to concerns regarding safety or effectiveness. This decision clears a regulatory path for the approval of generic versions of these specific dosages.
Klonopin, used to treat seizure and panic disorders, was first approved on April 9, 1997. While the brand-name manufac . . .
Klonopin, used to treat seizure and panic disorders, was first approved on April 9, 1997. While the brand-name manufac . . .